DBD Search
Vivian Berlin
Executive Director, HMS
Displaying: 71 - 75 of 75 Results
Research Tool
KRT14-cre Transgenic Mice
Mice hemizygous for the K14-Cre transgene are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. These transgenic mice express Cre recombinase under the control of the human keratin 14 promoter. Cre…
Investigators
- Andrew P. McMahon
Research Tool
Wnt7b Knock Out Mice
Mice that are heterozygous for the targeted mutation are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. Homozygous mice have an embryonic lethal phenotype, failing to develop past 11.5 days post…
Investigators
- Andrew P. McMahon
Research Tool
S100b-GCE
These transgenic mice express the eGFPCreERT2 (Enhanced Green Fluorescent Protein and cre/ESR1) fusion gene under the direction of the mouse S100b, S100 protein, beta polypeptide, neural, promoter. Transgene expression is detected in chondrocytes in…
Investigators
- Andrew P. McMahon
Research Tool
FoxD1GCE eGFPCreERT2 Transgenic Mice
Heterozygous mice are viable and fertile, normal in size and do not display any gross physical or behavioral abnormalities. The DI states that the strain is homozygous lethal. The Foxd1GCE allele expresses an eGFPCreERT2 fusion protein (EGFP and…
Investigators
- Andrew P. McMahon
Research Tool
Wnt11 knock-out
Mice heterozygous for this targeted mutation are viable and fertile with normal kidney size and histology. Homozygotes exhibit some embryonic lethality and will die by 2 days post partem. While the cause of death is unclear, these neonates have…
Investigators
- Andrew P. McMahon